NS Pharma’s Exon 53 Skipping Program Update
-Dr. Clemens and Lauren Morgenroth will review the phase 2 studies sponsored by NS Pharma about the investigational drug NS-065/NCNP-01.
-They will describe the study design, study progress, and early results of the 201 Phase 2 trial.
Meeting Title: NS Pharma’s Exon 53 Skipping Program Update
Date & Time: Wed, Jul 11, 2018, 1pm PDT / 4pm EDT
Web / Phone Access Information:
Toll-Free Dial-in Number: 866-519-2796
Participant Passcode: 811436
Register here: https://cc.readytalk.com/r/bodcjgagh4f8&eom